Enphase Energy Highlights IQ EV Charger 2 Is Ready As Is for EU AFIR ISO 15118-20 Charging StandardGlobeNewsWire · 4 days ago
Pasqal Achieves ISO/IEC 27001:2022 Certification for Its Information Security Management System Spanning R&D to Customer SupportGlobeNewsWire · Oct 15, 2026
Profusa Receives ISO 13485:2016 Certificate from GMEDGlobeNewsWire · Oct 15, 2026
China Automotive Systems' Fully Redundant AP04 EPS Platform Receives UL ISO 26262 ASIL-D Functional Safety Product CertificationPRNewsWire · Oct 9, 2026
NOVONIX Achieves ISO 9001 Quality Management CertificationGlobeNewsWire · Oct 7, 2026
Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early OctoberGlobeNewsWire · Sep 24, 2026IsoPlexis Corporation is a life sciences company dedicated to advancing the development of novel curative treatments and personalized therapeutics. The company's innovative offerings serve a wide international market, spanning North America (United States, Canada), numerous European nations (United Kingdom, Belgium, France, Czech Republic, Spain, Germany, Sweden, Italy, Switzerland), and key Asian and Pacific regions (Israel, China, Taiwan, Singapore, Japan, Australia, Korea). At its core, IsoPlexis provides a proprietary single-cell proteomics platform.